Phase 2 Obesity Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have a higher-than-normal level of LDL cholesterol (often called "bad" cholesterol), as measured according to the trial's specific guidelines (confirm with trial site)
Who may not be able to join:
- People who are planning to start or change the dose of any medication used to lower cholesterol or fats in the blood
- People who are currently using a type of cholesterol-lowering medication known as a PCSK9 inhibitor
Important: There are additional eligibility requirements not listed here that the trial site will assess. Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Clinical Trial Management, Regeneron Pharmaceuticals
Phone: 844-734-6643
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Percent change in LDL-C
Can't join this trial?
Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.